Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001144204-16-132226

10% owner acquired 38,833,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mayne Pharma Ventures Pty Ltd 10% owner 2016-11-04 Option exercise +5,500,000 154,562,230 D: show line 1 in the form
Mayne Pharma Ventures Pty Ltd 10% owner 2016-11-04 Option exercise +33,333,000 187,895,230 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mayne Pharma Ventures Pty Ltd 10% owner 2016-11-04 Option exercise · Warrant to Purchase Common Stock −5,500,000 4,750,569 D: show line 3 in the form
Mayne Pharma Ventures Pty Ltd 10% owner 2016-11-04 Option exercise · Warrant to Purchase Common Stock −33,333,000 333 D: show line 4 in the form
Loading xslF345X03/v452354_4.xml…